Home›Companies›Healthcare›AlloDirect

AlloDirect, Inc.

A platform for healthcare facilities to order human tissue directly from accredited tissue banks.

Updated Nov 11, 2026·Latest SEC filing Mar 6, 2026·Suggest an edit

About AlloDirect

AlloDirect is a private company based in Valparaiso, Indiana, incorporated in 2025 in Delaware. It has reported $110,000 raised in one offering on Form D since March 2026. Its chief executive is Rhett Barker.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 20, 2026Mar 6, 2026$110,000of $175K target5$22,000Equity, Simple Agreement for Future Equity (SAFE) ? convertible into preferred equity.Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on AlloDirect's Form D filed Mar 6, 2026.

Sources

  1. SECAlloDirect, Inc. filing history
  2. CompanyAlloDirect pre-seed announcement